Contract notice
Section I: Contracting
authority
I.1) Name and addresses
CELL AND GENE THERAPY CATAPULT
10016023
12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND
LONDON
SE19RT
UK
Telephone: +44 2037289500
E-mail: procurement@ct.catapult.org.uk
NUTS: UKI44
Internet address(es)
Main address: https://ct.catapult.org.uk/
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Consultants for Laboratory fit-out to the principles Universal Design
II.1.2) Main CPV code
79415200
II.1.3) Type of contract
Services
II.1.4) Short description
CGTC are looking for consultants to design and develop a laboratory for advanced therapy medicinal products (ATMPs) that meets the principles of Universal Design (UD) and can be scaled-out across the sector.
If you are interested in this opportunity please access the procurement document through our organisations E-tendering Portal, via the following link: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f
II.1.5) Estimated total value
Value excluding VAT:
275 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKM
II.2.4) Description of the procurement
CGTC are looking for consultants to design and develop a laboratory for advanced therapy medicinal products (ATMPs) that meets the principles of Universal Design (UD) and can be scaled-out across the sector.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
275 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 3
This contract is subject to renewal: Yes
Description of renewals:
Initial contract is 2 months, with the option to extend based of continuous need and satisfactory performance for an additional 1 month. ( 2+1 months)
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
14/10/2022
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.7) Conditions for opening of tenders
Date:
14/10/2022
Local time: 12:01
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
Catapult Cell and Gene Therapy
London
UK
VI.5) Date of dispatch of this notice
13/09/2022